Clinical pharmacokinetics of antiarrhythmic drugs.
D000813:Anilides / Q000378:metabolism / Q000627:therapeutic use; D000889:Anti-Arrhythmia Agents / Q000378:metabolism / Q000627:therapeutic use*; D001073:Aprindine / Q000378:metabolism / Q000627:therapeutic use; D001682:Biological Availability; D004206:Disopyramide / Q000378:metabolism / Q000627:therapeutic use; D006207:Half-Life; D006801:Humans; D008012:Lidocaine / Q000378:metabolism / Q000627:therapeutic use; D008801:Mexiletine / Q000378:metabolism / Q000627:therapeutic use; D010672:Phenytoin / Q000378:metabolism / Q000627:therapeutic use; D011342:Procainamide / Q000378:metabolism / Q000627:therapeutic use; D011433:Propranolol / Q000378:metabolism / Q000627:therapeutic use; D011802:Quinidine / Q000378:metabolism / Q000627:therapeutic use
D000813:Anilides; D000889:Anti-Arrhythmia Agents; D008801:Mexiletine; D001073:Aprindine; D010672:Phenytoin; D008012:Lidocaine; D011433:Propranolol; D004206:Disopyramide; D011802:Quinidine; D011342:Procainamide